NewsBenzingaStifel Maintains Hold on Immunome, Lowers Price Target to $23 Stifel Maintains Hold on Immunome, Lowers Price Target to $23 Benzinga 2026.11.10 14:42 (GMT+0) Open on Benzinga Other news Barclays Maintains Overweight on Kratos Defense & Security, Lowers Price Target to $80 IHS Holding Q3 EPS $0.08 Misses $0.27 Estimate, Sales $490.500M Beat $420.453M Estimate Hovde Group Initiates Coverage On East West Bancorp with Outperform Rating, Announces Price Target of $153 Barclays Maintains Underweight on Hain Celestial Group, Lowers Price Target to $0.1 Barclays Maintains Overweight on Ferguson Enterprises, Raises Price Target to $314 Bernstein Maintains Outperform on Lumentum Holdings, Raises Price Target to $700
Hovde Group Initiates Coverage On East West Bancorp with Outperform Rating, Announces Price Target of $153
